| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Galectin-3 |
|---|
| Ligand | BDBM50591139 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2199430 (CHEMBL5111946) |
|---|
| Kd | 37±n/a nM |
|---|
| Citation |  Zetterberg, FR; MacKinnon, A; Brimert, T; Gravelle, L; Johnsson, RE; Kahl-Knutson, B; Leffler, H; Nilsson, UJ; Pedersen, A; Peterson, K; Roper, JA; Schambye, H; Slack, RJ; Tantawi, S Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease. J Med Chem65:12626-12638 (2022) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Galectin-3 |
|---|
| Name: | Galectin-3 |
|---|
| Synonyms: | LEG3_HUMAN | LGALS3 | MAC2 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 26156.54 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P17931 |
|---|
| Residue: | 250 |
|---|
| Sequence: | MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPP
GAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNL
PLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNN
WGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDI
DLTSASYTMI
|
|
|
|---|
| BDBM50591139 |
|---|
| n/a |
|---|
| Name | BDBM50591139 |
|---|
| Synonyms: | CHEMBL5183295 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H21F3N4O5S |
|---|
| Mol. Mass. | 510.486 |
|---|
| SMILES | CC(=O)Nc1ccc(S[C@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)cc1 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
